BioTuesdays: Oramed hopes to start Phase 3 oral insulin trial next year

//BioTuesdays: Oramed hopes to start Phase 3 oral insulin trial next year

BioTuesdays: Oramed hopes to start Phase 3 oral insulin trial next year

Josh Hexter, Oramed’s COO, spoke with BioTuesdays.com about the conclusion of the Phase IIb study, and about what’s next for Oramed:

Oramed hopes to start Phase 3 oral insulin trial next year

2017-07-26T13:08:05+00:00 Categories: 媒体报导|